Phosphatidylserine Plus N-Acetylcysteine with Sarcosine
Phosphatidylserine Plus N-Acetylcysteine with Sarcosine, NPN 80134001: natural health product licensed in Canada. Medicinal ingredients: Acide N-méthylaminoacétique, Phosphatidylsérine, Acide L-alpha-acétamido-bêta-mercaptopropionique.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide N-méthylaminoacétique | 2,000 mg | Not calculated |
| Phosphatidylsérine Source : Phosphatidylserine | 300 mg | Not calculated |
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 600 mg | Not calculated |
Non-medicinal ingredients
Trehalose, Hydroxypropyle Cyclodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Cuillère à café | 1 Tous les jours |
Uses authorised in Canada
Source of/Provides antioxidants. Helps support cognitive health and/or brain function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
Do not use this product if you are taking antibiotics or nitroglycerin.
- Cautions and Warnings
Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant, breastfeeding or have kidney stones. Ask a health care practitioner before use if you have a history of prostate cancer. Ask a health care practitioner prior to use if you are taking antipsychotic medications.
Product record
- Licence holder
- LeralabInc
- NPN or DIN-HM
- 80134001
- Status
- Active licence
- Licence date
- 3 September 2024
- Revision date
- Not provided
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80134001
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Phosphatidylsérine
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Phosphatidylserine Plus N-Acetylcysteine with Sarcosine (LeralabInc): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80134001-phosphatidylserine-plus-n-acetylcysteine-with-sarcosine, updated 3 September 2024.